RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Global databases and social media each equip pharmaceutical companies with additional means for receiving adverse event reports.
The latest Cutting Edge Information study, “Driving Pharmacovigilance Success: Risk Management Plans and Adverse Event Reporting,” found that companies may also develop mobile applications geared toward transitioning pharmacovigilance data more easily among dedicated teams. Together, these resources fulfill a number of companies’ projected needs.
Companies may leverage databases to serve as a drug safety repository, housing adverse event reports and clinical databases under a single structure. The study uncovered a large number of pharmacovigilance teams that retain responsibility for managing companies’ global drug safety databases. Moreover, databases serve as an adverse event channel for 56% of surveyed companies.
Unlike traditional reporting channels, social media allows pharma to interact with those patients experiencing adverse events who may not initially document them. Fewer than half of pharmacovigilance teams at surveyed companies are currently involved in social media. However, use of social media forums such as YouTube, Facebook and Twitter may help pharmaceutical brand teams better manage adverse event reporting in consumer-driven therapeutic areas in the future.
Companies using mobile applications may facilitate inter-team communication and ensure that sales teams can quickly and accurately transmit drug safety information to pharmacovigilance and medical information teams. “Specifically, a company’s proprietary application allows its field forces to transmit adverse event data directly to a global drug safety database,” said Sarah Ray, research analyst at Cutting Edge Information. “Through use of its mobile application, drug companies can foster an additional layer of accountability for field forces and facilitate the flow of pharmacovigilance data across dedicated teams.”
The data in “Driving Pharmacovigilance Success: Risk Management Plans and Adverse Event Reporting” (http://www.cuttingedgeinfo.com/research/regulatory/drug-safety/) are designed to assist in companies’ drug safety efforts and elevate pharmacovigilance teams’ strategic impact through well-defined SOPs and social media tools.
Pharmacovigilance teams can use this report to:
- Optimize drug safety budgets and outsourced spending.
- Build a strong pharmacovigilance team and cultivate a drug safety culture companywide.
- Improve efficiency and develop best-in-class practices.
For more information about drug safety programs, contact Cassie Demeter at 919-403-6583.
